Adherence to Biologics, Hospitalizations, and Medical Costs in Patients with Ulcerative Colitis and Crohn’s Disease Using the MarketScan Commercial Claims and EncounterDatabase
Summary
Adherence to biologic therapies may result in lower hospitalization rates and inpatient costs in UC and Crohn’s patients.
DATE PUBLISHED
May 15, 2022
FORMAT
Poster
AUTHORS
Edward A Witt, Heather Kirkham, Renee Baiano